Less Ads, More Data, More Tools Register for FREE

Pin to quick picksCurrys Regulatory News (CURY)

Share Price Information for Currys (CURY)

Share Price is delayed by 15 minutes
Get Live Data
153.20    0.70 (0.46%)
Bid:
153.30
Ask:
153.50
Spread: 0.20 (0.13%)
Market Cap: £1.59b
CURY Live PriceLast checked at - London Stock Exchange

Intraday Currys Share Chart

Director/PDMR Shareholding

5 Apr 2023 10:30

RNS Number : 4750V
Currys PLC
05 April 2023
 

5 April 2023

CURRYS PLC

NOTIFICATION OF TRANSACTION OF DIRECTOR

Currys plc Buyout Award.

In accordance with the requirements of DTR 3.1 and Market Abuse Regulation Article 19, Currys plc (the 'Company') announces the following share transaction undertaken by Alex Baldock, Group Chief Executive (a PDMR).

Alex exercised the third and final tranche of the Company granted Buyout Award (the "Award") which was granted under Listing Rule 9.4.2(2) on 3 April 2018, and then vested on 6 April 2021. The final tranche of the award then became exercisable on the 3 April 2023. The exercise of nil cost options over ordinary shares of 0.1 pence will be settled using market purchase shares.

Alex exercised a total of 393,784 options, made up of 329,693 options and 64,091 accrued dividend equivalents and sold 185,731 shares to cover the tax liability arising on the transaction. The remaining 208,053 shares were retained.

PMDR DEALING NOTIFICATION

Notification and public disclosure of transactions by persons discharging managerial responsibilities and persons closely associated with them

1

Details of the person discharging managerial responsibilities/person closely associated

a)

Name

Alex Baldock

2

Reason for the notification

a)

Position/status

Group Chief Executive

b)

Initial notification/Amendment

Initial notification

3

Details of the issuer

a)

Name

Currys plc

b)

LEI

2138001E12GWLLDQQF16

4

Details of the transaction(s): section to be repeated for (i) each type of instrument; (ii) each type of transaction; (iii) each date; and (iv) each place where transactions have been conducted

a)

Description of the financial instrument, type of instrument

 

Ordinary shares of 0.1p each in Currys plc

Identification code

GB00B4Y7R145

b)

Nature of the transaction

Exercise of a share option under the Currys Long Term Incentive Plan ("LTIP")

c)

Price(s) and volume(s)

Price(s)

Volume(s)

Nil cost

393,784

£0.586716

185,731

 

 

d)

Aggregated information

-

Aggregated volume

-

Price

1. Exercise

Price(s)

Volume(s)

Total

Nil cost

393,784

 £0.00

 

2. Sale

Price(s)

Volume(s)

Total

£0.586716

185,731

 £108,971

e)

Date of the transaction

(DD-MM-YYYY)

04-04-2023

f)

Place of the transaction

London Stock Exchange (XLON)

 

Enquiries:

 

Sarah Thomas Deputy Company Secretary +44 (0)7401 373 188

 

Dan Homan Investor Relations Director +44 (0)7401 400 442

 

This information is provided by RNS, the news service of the London Stock Exchange. RNS is approved by the Financial Conduct Authority to act as a Primary Information Provider in the United Kingdom. Terms and conditions relating to the use and distribution of this information may apply. For further information, please contact rns@lseg.com or visit www.rns.com.RNS may use your IP address to confirm compliance with the terms and conditions, to analyse how you engage with the information contained in this communication, and to share such analysis on an anonymised basis with others as part of our commercial services. For further information about how RNS and the London Stock Exchange use the personal data you provide us, please see our Privacy Policy.
 
END
 
 
DSHGCGDSIDGDGXU
Date   Source Headline
24th Feb 20267:00 amRNSTransaction in Own Shares
20th Feb 20267:00 amRNSTransaction in Own Shares
19th Feb 20267:00 amRNSTransaction in Own Shares
18th Feb 202611:55 amRNSHolding(s) in Company
18th Feb 20267:00 amRNSTransaction in Own Shares
17th Feb 20267:00 amRNSTransaction in Own Shares
16th Feb 202612:20 pmRNSDirector/PDMR Shareholding
12th Feb 20267:00 amRNSTransaction in Own Shares
10th Feb 20267:00 amRNSTransaction in Own Shares
9th Feb 20267:00 amRNSTransaction in Own Shares
6th Feb 20267:00 amRNSTransaction in Own Shares
5th Feb 20267:00 amRNSTransaction in Own Shares
4th Feb 20267:00 amRNSTransaction in Own Shares
2nd Feb 20269:18 amRNSTotal Voting Rights
2nd Feb 20267:00 amRNSTransaction in Own Shares
30th Jan 20262:02 pmRNSDirector/PDMR Shareholding
30th Jan 20267:00 amRNSTransaction in Own Shares
29th Jan 20267:00 amRNSTransaction in Own Shares
28th Jan 20267:00 amRNSTransaction in Own Shares
27th Jan 20267:00 amRNSTransaction in Own Shares
26th Jan 20267:00 amRNSTransaction in Own Shares
23rd Jan 202610:27 amRNSHolding(s) in Company
23rd Jan 20267:00 amRNSTransaction in Own Shares
22nd Jan 20267:00 amRNSTransaction in Own Shares
21st Jan 20267:00 amRNSProfit guidance above market expectations
15th Jan 202612:59 pmRNSHolding(s) in Company
2nd Jan 20269:53 amRNSTotal Voting Rights
18th Dec 20257:00 amRNSPerformance continues to strengthen
1st Dec 202511:49 amRNSTotal Voting Rights
3rd Nov 202510:54 amRNSTotal Voting Rights
22nd Oct 20257:00 amRNSTransaction in Own Shares
21st Oct 20257:00 amRNSTransaction in Own Shares
20th Oct 20257:00 amRNSTransaction in Own Shares
17th Oct 20257:00 amRNSTransaction in Own Shares
16th Oct 20257:00 amRNSTransaction in Own Shares
15th Oct 20257:00 amRNSTransaction in Own Shares
14th Oct 20257:00 amRNSTransaction in Own Shares
13th Oct 20257:00 amRNSTransaction in Own Shares
10th Oct 20257:00 amRNSTransaction in Own Shares
9th Oct 20257:00 amRNSTransaction in Own Shares
8th Oct 20257:00 amRNSTransaction in Own Shares
7th Oct 20257:00 amRNSTransaction in Own Shares
6th Oct 20257:00 amRNSTransaction in Own Shares
3rd Oct 20252:21 pmRNSHolding(s) in Company
3rd Oct 20257:00 amRNSTransaction in Own Shares
2nd Oct 20257:00 amRNSTransaction in Own Shares
1st Oct 20254:40 pmRNSDirector/PDMR Shareholding
1st Oct 202510:07 amRNSTotal Voting Rights
1st Oct 20259:51 amRNSDirector/PDMR Shareholding
1st Oct 20257:00 amRNSTransaction in Own Shares

Due to London Stock Exchange licensing terms, we stipulate that you must be a private investor. We apologise for the inconvenience.

To access our Live RNS you must confirm you are a private investor by using the button below.